8-Dehydrocholesterol (BioCAD00000020035)
Metabolite Card
Formula: C27H44O (384.3392)
SMILES: [H][C@@]1(CC[C@@]2([H])C3=C(CC[C@]12C)[C@@]1(C)CC[C@H](O)CC1=CC3)[C@H](C)CCCC(C)C
Synonyms [en]
8-Dehydrocholesterol; 3b-Cholesta-5,8-dien-3-ol; 8-DHC; 8(9)-dehydrocholesterol; R85BA49SYS; UNII-R85BA49SYS
Last reviewed on 2024-06-28.
Cite this Page
8-Dehydrocholesterol. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000020035). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
8-Dehydrocholesterol (8-DHC) elevated concentration is one of the diagnostic biochemical hallmarks of classical Smith-Lemli-Opitz syndrome (SLOS). Plasma 8-DHC could be only marginally elevated. (PMID: 16435228). Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive condition caused by a defect in cholesterol synthesis (caused by a deficit of 3beta-hydroxysterol-Delta7 reductase). Affected children often have malformations and mental retardation. Autistic behaviors also are evident. In children, the baseline cholesterol, 8-DHC levels, and cholesterol levels following supplementation does not correlate with the presence or severity of autistic symptoms. (PMID: 16761297). Accumulation of 8-dehydrocholesterol in Amniotic fluid is diagnostic for SLOS. (PMID 16231320).
DBLinks
- CAS Registry Number: 70741-38-7
- PubChem CID: 129846
- ChEBI: 89982
- HMDB: HMDB0002027
- LipidMaps: LMST01010242
- KEGG:
- BioCyc:
- NCBI MeSH: cholesta-5,8-dien-3 beta-ol
- Wikipedia:
Other DBLinks
- CAS Registry Number: 70741-38-7
- PubChem: 129846
- ChEBI: ChEBI:89982
- HMDB: HMDB0002027
- LipidMaps: LMST01010242
- NCBI MeSH: cholesta-5,8-dien-3 beta-ol
- RefMet: RM0135610
- Coconut NaturalProduct: CNP0296511.1
Class / Ontology
- WishartLab ClassyFire: [Cholestane steroids] Cholestane steroids
- RefMet: [Cholesterols] Cholesterols
- LipidMaps: [Cholesterol and derivatives [ST0101]] Cholesterol and derivatives [ST0101]
- ChEBI: [CHEBI:89982] 8-Dehydrocholesterol
- Coconut NaturalProduct: [Cholestane steroids] Cholestane steroids
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| WikiPathways:WP4804 | Cholesterol biosynthesis with skeletal dysplasias |
| PathBank:SMP0120794 | Mevalonic Aciduria |
| PathBank:SMP0120464 | CHILD Syndrome |
| PathBank:SMP0120472 | Desmosterolosis |
| PathBank:SMP0120512 | Lysosomal Acid Lipase Deficiency (Wolman Disease) |
| PathBank:SMP0120573 | Cholesteryl Ester Storage Disease |
| PathBank:SMP0000023 | Steroid Biosynthesis |
| PathBank:SMP0000387 | CHILD Syndrome |
| PathBank:SMP0000112 | Risedronate Action Pathway |
| PathBank:SMP0000508 | Cholesteryl Ester Storage Disease |
| PathBank:SMP0087326 | Steroid Biosynthesis |
| PathBank:SMP0120685 | Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2) |
| PathBank:SMP0120769 | Hypercholesterolemia |
| PathBank:SMP0120793 | Hyper-IgD Syndrome |
| PathBank:SMP0120515 | Smith-Lemli-Opitz Syndrome (SLOS) |
| PathBank:SMP0120576 | Wolman Disease |
| PathBank:SMP0000389 | Smith-Lemli-Opitz Syndrome (SLOS) |
| PathBank:SMP0000319 | Lysosomal Acid Lipase Deficiency (Wolman Disease) |
| PathBank:SMP0000082 | Simvastatin Action Pathway |
| PathBank:SMP0000111 | Cerivastatin Action Pathway |